GIS · Q3 2026 Earnings

Bearish

General Mills

Reported March 18, 2026

30-second summary

30-second take: Q3 organic sales fell 3% and adjusted operating margin compressed to 12.3%, but the real news is the guide: FY26 organic sales cut from -1% to +1% down to -1.5% to -2%, and adjusted operating profit and EPS both cut from -10 to -15% constant currency to -16 to -20% — a 550bps midpoint deterioration that management framed as a "reaffirmation" of the outlook. The H2 acceleration thesis we flagged last quarter is now formally broken; the bull case has collapsed into a single Q4 print that needs to deliver a "step up in organic sales trends and return to earnings growth" with no quantified path beyond mechanical inventory and trade-timing tailwinds.

Headline numbers

EPS

Q3 FY2026

$0.64

Revenue

Q3 FY2026

$4.40B

-8.0% YoY

Gross margin

Q3 FY2026

30.8%

Operating margin

Q3 FY2026

11.8%

Key financials

Q3 FY2026

Metric	Q3 FY2026	YoY	Q2 FY2026	QoQ
Revenue	$4.40B	-8.0%	$4.90B	-10.2%
EPS	$0.64	—	$1.10	-41.8%
Gross margin	30.8%	—	34.8%	-400bps
Operating margin	11.8%	—	15.0%	-320bps

Guidance

Management significantly raised FY2026 headwinds, lowering full-year organic sales and earnings guidance despite reaffirming headline outlook; deterioration from Q3 actuals (-8% revenue, -3% organic sales) signals accelerating consumer pressure.

Guidance is issued for both next quarter and the full year. Both may appear below.

Changes to prior guidance

Metric	Period	Prior guide	New guide	Δ	Result
Organic net sales growth	FY 2026	down 1% to up 1%	down 1.5 to 2 percent	-0.5 to -1.0 percentage points	Lowered
Adjusted operating profit	FY 2026	down 10 to 15 percent in constant currency	down 16 to 20 percent in constant currency	-1 to -5 percentage points (widened range, lower midpoint)	Lowered
Adjusted diluted EPS	FY 2026	down 10 to 15 percent in constant currency	down 16 to 20 percent in constant currency	-1 to -5 percentage points (widened range, lower midpoint)	Lowered

Reaffirmed unchanged this quarter: Free cash flow conversion (at least 95 percent of adjusted after-tax earnings)

Segment performance

Q3 FY2026

Segment	Q3 FY2026	YoY
North America Retail	$2.6B	-14.0%
North America Pet	$0.64B	+3.0%
North America Foodservice	$0.496B	-11.0%
International	$0.696B	+7.0%

Platform metrics

Q3 FY2026

Segment	Q3 FY2026
Organic Net Sales Growth (Q3)	-3%
North America Retail Organic Volume Change	-3 pts
North America Pet Organic Volume Change	-6 pts
International Organic Net Sales Growth	+1%
Diluted Shares Outstanding (Average)	537.3M

Profitability

Q3 FY2026

Segment	Q3 FY2026
Adjusted Gross Margin	30.6%
Adjusted Operating Profit Margin	12.3%
Operating Cash Flow (9M)	$1.6B

Management tone

No transcript was available for this quarter; the read below is anchored in the press-release language versus the prior three quarters' guide framing and outlook commentary. The Q&A excerpts referenced reflect the press release's earnings-call summary, not a full transcript.

Q4 FY25 "investment year to restart growth" → Q1 FY26 "category growth below long-term projections" → Q2 FY26 "winning is not just about price" → Q3 FY26 "step up in trends and return to earnings growth in Q4."

The growth thesis has now been compressed into a single quarter. Last quarter management spread the recovery across H2 with the help of trade timing and the 53rd week; this quarter, having watched Q3 organic flatline at -3% and gross margin collapse 420bps, the framing is that the recovery happens in Q4 specifically — and the FY destination has moved lower to make that recovery achievable. The transition from "the categories are weaker" (Q1) to "winning is not just about price" (Q2) to "we expect a step up... and return to earnings growth in Q4" (Q3) is the language of a management team that has tried three different narratives in three quarters and is now anchoring on a single-quarter mechanical bridge.

The Q2 pre-announcement of Q3 weakness was directionally honest but quantitatively insufficient. Last quarter, Bruce told the buy-side that "all of those" Q2 favorability items would reverse in Q3. They did — adj. EPS fell from $1.10 to $0.64 sequentially and adj. gross margin fell 420bps to 30.6%. But the magnitude has now driven a 550bps cut to the FY adj. operating profit guide, which suggests either the reversal exceeded internal models or H2 deterioration was running broader than the "favorability reverses" framing acknowledged. Either reading means management's forward visibility into its own P&L has tightened materially.

The confidence language has moved from softened to assertive — which in this context reads as defensive. Q3 outlook copy includes "we are confident in our ability to deliver improved organic sales results while continuing to generate industry-leading cost efficiency." That's a firmer rhetorical posture than Q2's "winning is not just about price." Coming alongside a 550bps EPS guide cut, the assertion that improvement is coming reads as managing expectations toward Q4, not signaling underlying conviction. The pattern — guide-cut paired with elevated confidence language — is the same one we flagged in the Q4 FY25 brief ("repeated confidence language suggests management knows the room is skeptical") and it has now repeated for the third consecutive quarter.

The Q&A surfaces an FY27 setup that is now the bull case by default. Lazar, Jordan, Palmer, and Lavery all spent meaningful time on FY27 mechanics: lapping of price investments starting with Pillsbury, then cereal, then fruit snacks; innovation tracking at ~25% with named carryover drivers (Cheerios Protein at $100M run rate, Ghost Protein Bars going national); a Street gross margin estimate near 34% for FY27 with management willing to specify a target after Q4. Management did not push back on this framing, in contrast to Bruce's Q2 refusal to "build too heavily for F27." That shift — from declining to engage on FY27 to leaning into the FY27 setup as the recovery story — is the most telling change of the call. It implies management has internally concluded that FY26 is no longer the year the bull case is made.

Q&A highlights

Andrew Lazar · Barclays

Can General Mills return to volume growth in fiscal 27 given pricing investments behind it and category growth remaining below longer-term levels? What competitive pricing actions have been observed in key categories following GM's own price investments?

Management expects to increase dollar share competitiveness in FY27 while maintaining pound share, leveraging innovation and improved marketing ROI. Price mix was negative this year due to base shelf price investments (not promotional activity), but this will lap in FY27 starting with Pillsbury, then cereal, then fruit snacks. Expects return to price mix growth in FY27. Competitor price mix has been modest, driven by small brand innovation.

Price mix down this year due to base shelf price correctionsPrice gaps vs. competition to approach pre-COVID levels in FY27Lapping of price investments starting in early FY27Pillsbury to lead price recovery, followed by cereal and fruit snacks

Leah Jordan · Goldman Sachs

How is innovation resonating with consumers relative to the 25% growth goal? What new products are driving growth in NAR and what should be expected for seasonal events and FY27?

Innovation tracking at ~25% portfolio-wide, slightly higher in NAR (approaching or exceeding 25%). Key drivers include Cheerios Protein ($100M run rate), taste renovations in salty snacks and fruit snacks showing strong trial/repeat. FY27 pipeline includes protein additions to Honey Nut Cheerios, Ghost Protein Bars (scaling nationally), fiber-focused products (Annie's fruit snacks, Larabar, Ratio granola), and bold flavors (La Tiara Mexican brand, hot honey Pillsbury biscuits, Tabasco Old El Paso kits). Supporting with double-digit media investment and seasonal events.

Innovation tracking 25% or slightly higher in NAR, 20-25% portfolio aggregateCheerios Protein reaching $100M revenue run rateStrong trial and repeat rates on new products driving FY27 carry-over benefitsFY27 pipeline includes Honey Nut Cheerios Protein, Ghost Protein Bars national launch, fiber-enhanced products

David Palmer · Evercore ISI

How do current spending levels and responses on innovation, promotion, and marketing compare to pre-COVID? What is different in terms of competitive responses? Where can gross margins reach in FY27 assuming stable organic sales?

Current innovation and marketing spending approaching pre-COVID levels (~5% of sales), with price competitiveness now also approaching pre-COVID levels after recent investments. Core renovation quality is actually better than pre-COVID. Key difference: consumer stress is higher than 2019, driving increased (but not deeper/more frequent) promotion activity. Gross margins can stabilize/improve with stable-to-growing volume; leverage from volume, HMM savings, and transformation initiatives expected to aid restoration. Will provide specific FY27 margin target guidance in Q4/Q1.

Innovation and marketing spending approaching pre-COVID levels (~5% of sales)Base price competitiveness gap approaching pre-COVID levelsCore renovation quality better than pre-COVIDVolume stability/growth required for margin expansion

Michael Lavery · Piper Sandler

What is the inflation outlook for FY27, both with and without elevated oil/diesel costs? How much do HMM savings need to work to offset inflation? Will Q4 show positive organic revenue growth or just improved trends?

FY27 inflation estimated roughly in line with FY26, potentially with modest macro basket pressure at far end of range. Labor remains largest inflationary component. Expects another year of industry-leading HMM (at least 4%) plus significant transformation initiative contributions. Q4 organic growth implied ~75-80 bps from guidance midpoint, driven primarily by mechanical factors: ~200 bps benefit from retailer inventory reset (implies ~50 bps in-quarter), reversal of trade expense timing headwinds from Q3. Not banking on dramatic market performance turn in Q4. FY27 headwinds include 53rd week lapping (headwind), loss of one month yogurt results, normalized incentive comp.

FY27 inflation expected roughly in line with FY26Labor inflation remains largest cost pressureHMM savings expected at least 4% in FY27Retailer inventory reset worth ~200 bps benefit annualized (~50 bps Q4)

Robert Moscow · TD Cowan

Why is snacks declining at high single digits? Is the competitive price/innovation pressure in salty snacks carving into GM brands? What drives return to growth in snacks?

Snacks decline driven primarily by Totino's (hot snacks), not broad-based salty snack weakness. Salty snacks category showing three consecutive quarters of pound and dollar share gains; GM brands responding well to price investments and flavor renovation. Totino's challenge was price-pack architecture conversion (bag-to-box) that didn't resonate in stressed consumer environment; now converting back to bag format with improved pricing and product quality messaging. Excluding Totino's, snacks still down slightly due to grain business (Nature Valley performing well, but Fiber One still down despite GLP-1 user uptick). Focus for recovery: scale Ghost protein bars, maintain Nature Valley momentum, double down on GLP-1 users (Fiber One, Protein One), improve Totino's product quality and messaging.

Salty snacks on double-digit growth in Q3; three consecutive quarters of share gainsTotino's underperforming due to bag-to-box price-pack conversionConverting Totino's back to bag format with improved pricingEx-Totino's snacks still down slightly, primarily grain business

Answers to last quarter's watch list

Q3 organic net sales for North America Retail. Printed at -3% — flatlined from Q2's -3% rather than improving to the -1% to flat range the watch list called for. Two consecutive quarters of no progress on the gating segment is the negative scenario we flagged. Status: Resolved negatively

Adjusted gross margin in Q3. Printed at 30.6% — a 420bps QoQ collapse from Q2's 34.8% and below the 33% line we explicitly flagged as the trigger for the broad-price-erosion concern. The FY guide cut on operating profit confirms the read. Status: Resolved negatively

Whether Q3 adj. EPS is up or down YoY — and the gap to Q4. Q3 adj. EPS of $0.64 fell sharply from Q2's $1.10 and is materially below the year-ago comparable. The implied Q4 print to land at the new (lower) FY range now sits in a band of roughly $0.85 to $1.00 by the press release math — a single-quarter print that carries the entire FY credibility. The FY range guide cut itself confirms the prior bar was untenable. Status: Resolved negatively

Pet organic ex-Wilderness. Pet reported +3% but organic volume contribution turned -6pts — the bull-case Q2 +1% organic flip has unwound. No Blue Buffalo brand-specific organic disclosure visible in the press release. Status: Resolved negatively

Totino's read after the bag-to-box conversion. Moscow's Q&A surfaced that Totino's is being reversed back to bag format with improved pricing and quality messaging — i.e., the bag-to-box conversion did not work and is being unwound. The price investment thesis on Totino's failed; the recovery now depends on the reversal sticking. Status: Resolved negatively

First commentary on FY27 setup. Management engaged substantively on FY27 across four analyst exchanges — Lazar (price-mix lap), Jordan (innovation pipeline), Palmer (margin path), Lavery (inflation and headwinds). This is a shift from Bruce's Q2 refusal to "build too heavily for F27." Specific FY27 gross margin target deferred to Q4 or Q1 FY27 disclosure. Status: Resolved positively (qualified: management engaged because FY27 is now the recovery story, not because FY26 is on track)

What to watch into next quarter

Whether Q4 adj. EPS lands inside the implied $0.85-$1.00 band needed to reach the new FY range. A miss would require a second FY guide cut and effectively end the credibility of the H2 recovery framing for FY26.

Whether Q4 adj. gross margin recovers above 32%. Q3 at 30.6% breaks the 33% line. Management's "step up in trends" language implies sequential margin improvement; below 32% in Q4 means the operational anchor is gone and the FY27 ~34% Street bogey looks ambitious.

The specific FY27 gross margin target Bruce committed to specify in Q4 or Q1 FY27. Palmer flagged the Street estimate near 34%. Anything below 33% would force a meaningful re-rate of the FY27 recovery thesis; anything above 34% extends the credibility runway.

Q4 North America Retail organic sales. Three consecutive quarters at -3% to -5% with no sequential improvement means the price-investment-restarts-volume thesis has not worked. Q4 needs to print better than -2% to validate the FY27 lap setup; -3% again would mean four consecutive quarters of flatlining on the gating segment.

Quantified Q4 mechanical contribution (retailer inventory reset and trade-expense timing reversal). Lavery's Q&A sized these at roughly 50bps in-quarter Q4 lift and a Q3-to-Q4 trade swing. If the actual Q4 organic print is below the implied +75-80bps without these benefits, underlying market performance deteriorated further.

Any further Totino's read post-bag-reversal. The portfolio's one named pricing failure being unwound is a discrete event with a measurable outcome by Q4. A clean read on Totino's revenue trajectory will indicate whether the broader "targeted value investment" framework is recoverable.

Sources

General Mills Q3 fiscal 2026 press release (SEC filing): https://www.sec.gov/Archives/edgar/data/40704/000162828026019020/a20260318ex99.htm
Tapebrief Q2 FY2026 brief (December 17, 2025) for prior watch list and guidance baselines.
Tapebrief Q1 FY2026 brief (September 17, 2025) for narrative arc context.
Tapebrief Q4 FY2025 brief (June 25, 2025) for original FY26 guide framing and FY25 adj. EPS base of $4.21.

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.